These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25525201)

  • 1. β-Lactamase inhibition by avibactam in Mycobacterium abscessus.
    Dubée V; Bernut A; Cortes M; Lesne T; Dorchene D; Lefebvre AL; Hugonnet JE; Gutmann L; Mainardi JL; Herrmann JL; Gaillard JL; Kremer L; Arthur M
    J Antimicrob Chemother; 2015 Apr; 70(4):1051-8. PubMed ID: 25525201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the β-Lactamase Bla
    Lefebvre AL; Le Moigne V; Bernut A; Veckerlé C; Compain F; Herrmann JL; Kremer L; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096155
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab β-lactamase on the in vitro and intracellular efficacy of imipenem.
    Le Run E; Atze H; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2020 Feb; 75(2):379-383. PubMed ID: 31637424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
    Lefebvre AL; Dubée V; Cortes M; Dorchêne D; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2016 Jun; 71(6):1556-63. PubMed ID: 26929268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of avibactam renders piperacillin an effective treatment for
    Meir M; Bifani P; Barkan D
    Antimicrob Resist Infect Control; 2018; 7():151. PubMed ID: 30564307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus.
    Lopeman RC; Harrison J; Rathbone DL; Desai M; Lambert PA; Cox JAG
    Sci Rep; 2020 Jan; 10(1):928. PubMed ID: 31988293
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate.
    Soroka D; Ourghanlian C; Compain F; Fichini M; Dubée V; Mainardi JL; Hugonnet JE; Arthur M
    J Antimicrob Chemother; 2017 Apr; 72(4):1081-1088. PubMed ID: 28039278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors.
    Dousa KM; Kurz SG; Taracila MA; Bonfield T; Bethel CR; Barnes MD; Selvaraju S; Abdelhamed AM; Kreiswirth BN; Boom WH; Kasperbauer SH; Daley CL; Bonomo RA
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393499
    [No Abstract]   [Full Text] [Related]  

  • 11. The β-Lactams Strike Back: Ceftazidime-Avibactam.
    Zasowski EJ; Rybak JM; Rybak MJ
    Pharmacotherapy; 2015 Aug; 35(8):755-70. PubMed ID: 26289307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Dubée V; Soroka D; Cortes M; Lefebvre AL; Gutmann L; Hugonnet JE; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2015 May; 59(5):2938-41. PubMed ID: 25733512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections.
    Nicolau DP
    Expert Opin Investig Drugs; 2015; 24(9):1261-73. PubMed ID: 26145447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex.
    Misawa K; Nishimura T; Kashimura S; Enoki Y; Taguchi K; Uno S; Uwamino Y; Matsumoto K; Hasegawa N
    Int J Antimicrob Agents; 2022; 60(5-6):106669. PubMed ID: 36064079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus.
    Sanchez L; Bitar M; Herail Q; Dorchêne D; Hugonnet JE; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38943535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
    Negatu DA; Zimmerman MD; Dartois V; Dick T
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0079022. PubMed ID: 36047786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase.
    Soroka D; Dubée V; Soulier-Escrihuela O; Cuinet G; Hugonnet JE; Gutmann L; Mainardi JL; Arthur M
    J Antimicrob Chemother; 2014 Mar; 69(3):691-6. PubMed ID: 24132992
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical Characterization of β-Lactamases from Mycobacterium abscessus Complex and Genetic Environment of the β-Lactamase-Encoding Gene.
    Ramírez A; Ruggiero M; Aranaga C; Cataldi A; Gutkind G; de Waard JH; Araque M; Power P
    Microb Drug Resist; 2017 Apr; 23(3):294-300. PubMed ID: 27429159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.